Tiara Harrison, in Se, DC - Dentist

Tiara Harrison, is a Dentist based in Se, District Of Columbia. Tiara Harrison is licensed to practice in Virginia (license number 0401414821) and her current practice location is 1100 Alabama Ave., Se, District Of Columbia. She can be reached at her office (for appointments etc.) via phone at (202) 299-5178.

NPI number for Tiara Harrison is 1013397454 and her current mailing address is 3709 Julep Dr, South Chesterfield, Virginia. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1013397454.

Contact Information

	Tiara Harrison,
	1100 Alabama Ave., Se, DC 20023
	(202) 299-5178
	Not Available

Healthcare Provider's Profile

Full Name	Tiara Harrison
Gender	Female
Speciality	Dentist
Location	1100 Alabama Ave., Se, District Of Columbia
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1013397454
Provider Enumeration Date: 06/01/2015
Last Update Date: 06/01/2015

Medical Identifiers

Medical identifiers for Tiara Harrison such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013397454	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
122300000X	Dentist	0401414821 (Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Tiara Harrison is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Tiara Harrison, 3709 Julep Dr, South Chesterfield, VA 23834-5635 Ph: () -	Tiara Harrison, 1100 Alabama Ave., Se, DC 20023 Ph: (202) 299-5178

News Archive

Higher incidence of rejection following early steroid withdrawal

A new study on early steroid withdrawal following liver transplantation found that there was a higher incidence of rejection and a lower incidence of glucose intolerance necessitating treatment for diabetes.

New palonosetron-aprepitant trial data on chemotherapy induced nausea, vomiting presented at EHA

New data presented at the European Hematology Association (EHA) 2011 Annual Meeting in London show better control of nausea and vomiting with the combination palonosetron plus aprepitant when compared to granisetron in patients receiving multiday highly emetogenic conditioning chemotherapy regimens - Significantly higher the complete response during the acute, delayed and overall periods.

SARS-CoV-2 alpha variant increased COVID-19 severity in Scotland's 3rd wave

A team of UK-based scientists has recently revealed that the alpha variant (B.1.1.7) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the third pandemic wave in Scotland and that the variant is associated with more severe coronavirus disease 2019 (COVID-19). The study is currently available on the medRxiv* preprint server.

New antibody can be used as early diagnostic tool for Parkinson's

Conditions such as Parkinson's disease are a result of pathogenic changes to proteins. In the neurodegenerative condition of Parkinson's disease, which is currently incurable, the alpha-synuclein protein changes and becomes pathological. Until now, there have not been any antibodies that could help to demonstrate the change in alpha-synuclein associated with the disease. An international team of experts led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now discovered a new antibody that actually possesses this ability.

Tiara Harrison, - Dentist in Se, DC